American Century Companies Inc. Sells 25,050 Shares of Ryan Specialty Holdings Inc. $RYAN

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

American Century Companies Inc. lowered its holdings in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 2.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,109,234 shares of the company's stock after selling 25,050 shares during the period. American Century Companies Inc. owned about 0.42% of Ryan Specialty worth $81,939,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Liontrust Investment Partners LLP acquired a new stake in Ryan Specialty during the first quarter worth $758,000. Lord Abbett & CO. LLC acquired a new stake in Ryan Specialty during the first quarter worth $27,928,000. LGT Group Foundation acquired a new stake in Ryan Specialty during the first quarter worth $1,463,000. Russell Investments Group Ltd. boosted its stake in Ryan Specialty by 4.4% during the first quarter. Russell Investments Group Ltd. now owns 13,642 shares of the company's stock worth $1,008,000 after buying an additional 569 shares in the last quarter. Finally, Nuveen LLC acquired a new stake in Ryan Specialty during the first quarter worth $26,739,000. Institutional investors and hedge funds own 84.82% of the company's stock.

Analyst Upgrades and Downgrades

RYAN has been the topic of a number of recent research reports. UBS Group decreased their price target on shares of Ryan Specialty from $84.00 to $80.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. Cantor Fitzgerald upgraded shares of Ryan Specialty to a "hold" rating in a research note on Wednesday, August 13th. Morgan Stanley reduced their target price on shares of Ryan Specialty from $71.00 to $68.00 and set an "overweight" rating on the stock in a research note on Monday. Barclays reduced their target price on shares of Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating on the stock in a research note on Monday, July 7th. Finally, Wall Street Zen upgraded shares of Ryan Specialty from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. Nine research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $74.83.

Insider Activity

In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,377 shares of the business's stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the sale, the executive vice president directly owned 1,117 shares of the company's stock, valued at approximately $73,543.28. The trade was a 92.79% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director David P. Bolger sold 5,000 shares of the business's stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total value of $354,000.00. Following the sale, the director directly owned 71,467 shares of the company's stock, valued at $5,059,863.60. This represents a 6.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 52.21% of the company's stock.

Ryan Specialty Price Performance

Shares of Ryan Specialty stock traded up $0.0360 during trading on Thursday, reaching $59.7960. The company's stock had a trading volume of 1,075,486 shares, compared to its average volume of 1,079,582. The stock has a 50-day moving average price of $63.87 and a two-hundred day moving average price of $67.58. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.88. Ryan Specialty Holdings Inc. has a one year low of $55.77 and a one year high of $77.16. The stock has a market capitalization of $15.77 billion, a P/E ratio of 170.85, a price-to-earnings-growth ratio of 1.64 and a beta of 0.64.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported $0.66 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.66. Ryan Specialty had a return on equity of 48.70% and a net margin of 6.81%.The business had revenue of $855.17 million during the quarter, compared to analysts' expectations of $837.52 million. During the same period in the previous year, the business posted $0.58 earnings per share. The firm's revenue for the quarter was up 23.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, August 26th. Investors of record on Tuesday, August 12th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, August 12th. Ryan Specialty's payout ratio is currently 137.14%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.